About the Authors
- Julie Lorin
-
Affiliation Laboratory of Cardiometabolic Physiopathology and Pharmacology, INSERM UMR 866, UFR Sciences de Santé, Université de Bourgogne, Dijon, France
- Jean-Claude Guilland
-
Affiliation Laboratory of Cardiometabolic Physiopathology and Pharmacology, INSERM UMR 866, UFR Sciences de Santé, Université de Bourgogne, Dijon, France
- Karim Stamboul
-
Affiliations Laboratory of Cardiometabolic Physiopathology and Pharmacology, INSERM UMR 866, UFR Sciences de Santé, Université de Bourgogne, Dijon, France, Service de Cardiologie, CHU Dijon, France
- Charles Guenancia
-
Affiliations Laboratory of Cardiometabolic Physiopathology and Pharmacology, INSERM UMR 866, UFR Sciences de Santé, Université de Bourgogne, Dijon, France, Service de Cardiologie, CHU Dijon, France
- Yves Cottin
-
Affiliations Laboratory of Cardiometabolic Physiopathology and Pharmacology, INSERM UMR 866, UFR Sciences de Santé, Université de Bourgogne, Dijon, France, Service de Cardiologie, CHU Dijon, France
- Luc Rochette
-
Affiliation Laboratory of Cardiometabolic Physiopathology and Pharmacology, INSERM UMR 866, UFR Sciences de Santé, Université de Bourgogne, Dijon, France
- Catherine Vergely
-
Affiliation Laboratory of Cardiometabolic Physiopathology and Pharmacology, INSERM UMR 866, UFR Sciences de Santé, Université de Bourgogne, Dijon, France
- Marianne Zeller
-
* E-mail: marianne.zeller@u-bourgogne.fr
Affiliation Laboratory of Cardiometabolic Physiopathology and Pharmacology, INSERM UMR 866, UFR Sciences de Santé, Université de Bourgogne, Dijon, France
Competing Interests
The authors have declared that no competing interest exist.
Author Contributions
Funding acquisition: YC CV LR. Methodology: JCG KS. Project administration: CG KS JL. Resources: CV. Supervision: YC MZ. Validation: JCG. Writing – original draft: JL. Writing – review & editing: MZ.